Luiz Carlos Maia Ladeira

Mr. Luiz Carlos Maia Ladeira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Foods
Verified
Journal Article
Open access
PDF file
Luiza de Paula Dias MoreiraLuiza de Paula Dias Moreira
Luiza de Paula Dias Moreira
BEBárbara Nery Enes
Bárbara Nery Enes
VJVinícius Parzanini Brilhante de São José
Vinícius Parzanini Brilhante de São José
RTRenata Celi Lopes Toledo
Renata Celi Lopes Toledo
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
HMHercia Martino
Hercia Martino
We hypothesized that the consumption of chia (Salvia hispanica L.) flour (CF) and chia oil (CO) improves metabolic disorders in the liver of Wistar rats (Rattus norvegicus domestica) fed a high-fat and high-fructose (HFHF) diet. The animals were fed a HFHF diet (n = 30) or AIN93-M standard diet (n = 10) for eight weeks. After this period, the animals fed HFHF were divided into three groups (n = 10): HFHF diet, HFHF plus 14.7% of CF, and HFHF plus 4% of CO. Histological and biochemical analyses, gene expression, protein levels related to inflammation, and oxidative stress were evaluated in the liver. The HFHF diet caused lipogenesis, liver steatosis, oxidative stress, and inflammation in the animals. The CF and CO intake increased the liver total antioxidant capacity and superoxide dismutase, decreased nitric oxide levels and liver steatosis. Furthermore, the CF and CO led to the upregulation of Cpt1a and Adipor2, respectively, whereas CF downregulated Srebf1. CO intake decreased blood glucose, triglycerides, and the animals’ body weight. Chia did not show effects on mitigating liver pro-inflammatory status, which it may indicate occurs later. The addition of chia into an unbalanced diet is a good and relevant strategy to reduce liver metabolic disorders caused by the high consumption of fructose and saturated fat.

1 June 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
ESEliziária Cardoso dos Santos
Eliziária Cardoso dos Santos
TSTalita Amorim Santos
Talita Amorim Santos
JSJanaina da Silva
Janaina da Silva
GLGraziela Domingues de Almeida Lima
Graziela Domingues de Almeida Lima
IMIzabel Regina dos Santos Costa Maldonado
Izabel Regina dos Santos Costa Maldonado

25 October 2019 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
ESEliziária Cardoso dos Santos
Eliziária Cardoso dos Santos
GVGilmar Edilberto Valente
Gilmar Edilberto Valente
JSJanaina da Silva
Janaina da Silva
TSTalita Amorim Santos
Talita Amorim Santos
IMIzabel Regina dos Santos Costa Maldonado
Izabel Regina dos Santos Costa Maldonado

18 July 2025 in Toxicology
Verified
Journal Article
Open access
BBBrian Bwanya
Brian Bwanya
SLSaad Salman Khan Lodhi
Saad Salman Khan Lodhi
TKTheo M. de Kok
Theo M. de Kok
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
MVMarcha Ct Verheijen
Marcha Ct Verheijen
FCFlorian Caiment
Florian Caiment
The transition toward new approach methodologies for toxicity testing has accelerated the development of computational models that utilize transcriptomic data to predict chemical-induced adverse effects. Here, we applied supervised machine learning to gene expression data derived from primary human hepatocytes and rat liver models (in vitro and in vivo) to predict drug-induced hepatic steatosis. We evaluated five machine learning classifiers using microarray data from the Open TG-GATEs database. Among these, support vector machine (SVM) consistently achieved the highest performance, with area under the receiver operating characteristic curve (ROC-AUC) of 0.820 in primary human hepatocytes, 0.975 in the rat in vitro model, and 0.966 in the rat in vivo model. To gain mechanistic insights, we functionally profiled the top-ranked predictive genes. Enrichment analyses revealed strong associations with lipid metabolism, mitochondrial function, insulin signalling, oxidative stress, all biological processes central to steatosis pathogenesis. Key predictive genes such as CYP1A1, PLIN2, and GCK mapped to lipid metabolism networks and liver disease annotations, while others highlighted novel transcriptomics signals. Integration with differentially expressed genes and known steatosis markers highlighted both overlapping and distinct molecular features, suggesting that machine learning models capture biologically relevant signals. These findings demonstrate the potential of machine learning models guided by transcriptomic data to identify early molecular signatures of drug-induced hepatic steatosis. The support vector machine model's strong predictive accuracy across species highlights its promise as a scalable and interpretable tool for chemical risk assessment. As data limitations in human toxicology persist, expanding high-quality transcriptomic resources will be critical to further advance non-animal approaches in regulatory toxicology.

7 April 2025 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
DBDevon A. Barnes
Devon A. Barnes
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
RMRosalinde Masereeuw
Rosalinde Masereeuw

1 January 2023 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
FDFernanda Dias
Fernanda Dias
MCMarli do Carmo Cupertino
Marli do Carmo Cupertino
PSP. G. Silva
P. G. Silva
EOE. L. Oliveira
E. L. Oliveira
LLLuiz Carlos Maia Ladeira
Luiz Carlos Maia Ladeira
MGMarcos Lucca Moreira Gomes
Marcos Lucca Moreira Gomes
Medicinal plant species are genetically engineered to obtain higher production of biomass and specific secondary metabolites, which can be used in the pharmaceutical industry. The aim of the present study was to evaluate the effect of Pfaffia glomerata (Spreng.) Pedersen tetraploid hydroalcoholic extract on the liver of adult Swiss mice. The extract was prepared from the plant roots and given to the animals by gavage, for 42 days. The experimental groups were treated with water (control), Pfaffia glomerata tetraploid hydroalcoholic extract (100, 200 and 400 mg/kg) and Pfaffia glomerata tetraploid hydroalcoholic extract discontinuously (200 mg/kg). The last group received the extract every 3 days, for 42 days. The oxidative status, mineral dynamics, and cell viability were analysed. The liver weight and the number of viable hepatocytes were reduced, despite the increased cell’s number. Increased levels of malondialdehyde and nitric oxide, and changes in iron, copper, zinc, potassium, manganese and sodium levels were observed. aspartate aminotransferase levels were increased while alanine aminotransferase levels were decreased due to BGEt intake. Our results showed that BGEt induced alterations of oxidative stress biomarkers leading to liver injury, which was associated with a reduction in the number of hepatocytes.